SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Dr. Sean McCarthy, PhD, will speak at the Duke Beijing Healthcare Forum.
News | 05. 26. 2007
